Cargando…

Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia

BACKGROUND: Bacteremia in adult patients has traditionally been treated with extended courses of intravenous antibiotics. Data on the use of (or rapid transition to) oral therapy are limited. METHODS: Adult infectious disease physicians participating in the Infectious Diseases Society of America Eme...

Descripción completa

Detalles Bibliográficos
Autores principales: Hospenthal, Duane R, Waters, C Dustin, Beekmann, Susan E, Polgreen, Philip M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731529/
https://www.ncbi.nlm.nih.gov/pubmed/33335941
http://dx.doi.org/10.1093/ofid/ofz386
_version_ 1783621917285023744
author Hospenthal, Duane R
Waters, C Dustin
Beekmann, Susan E
Polgreen, Philip M
author_facet Hospenthal, Duane R
Waters, C Dustin
Beekmann, Susan E
Polgreen, Philip M
author_sort Hospenthal, Duane R
collection PubMed
description BACKGROUND: Bacteremia in adult patients has traditionally been treated with extended courses of intravenous antibiotics. Data on the use of (or rapid transition to) oral therapy are limited. METHODS: Adult infectious disease physicians participating in the Infectious Diseases Society of America Emerging Infections Network (EIN) were surveyed regarding their use of oral antibiotics in patients with bacteremia. Respondents were asked to assume that patients were hemodynamically stable, recovered bacteria were susceptible to potential antibiotics, adequate source control had been achieved, and patients had adequate gastrointestinal absorption. Variables of specific bacteria, oral agent, and associated infection were included. RESULTS: A total of 655 (50%) of 1321 EIN participants responded. Under certain conditions, 88% would transition patients with Gram-negative bacteremia to complete a course of therapy with oral antibiotics; 71% would transition patients with Gram-positive bacteremia to oral agents. Only 78 (12%) respondents would not treat any bacteremic patient with oral agents. Most respondents (≥75%) were comfortable treating infections secondary to Enterobacteriaceae, Salmonella, Pseudomonas, Stenotrophomonas, Streptococcus pneumoniae, and β-hemolytic streptococci with oral agents. Fewer than 20% endorsed use of oral antibiotics for Staphylococcus aureus or in cases of endocarditis. Fluoroquinolones and trimethoprim-sulfamethoxazole were the preferred agents in Gram-negative bacteremia; linezolid and β-lactams were the preferred agents in Gram-positive bacteremia. CONCLUSIONS: In select circumstances, the majority of respondents would transition patients to oral antibiotics, in both Gram-negative and Gram-positive bacteremia. Most agreed with the use of oral agents in Gram-negative bacteremia caused by Enterobacteriaceae, but they would not use oral agents for Gram-positive bacteremia caused by S aureus or in endocarditis.
format Online
Article
Text
id pubmed-7731529
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77315292020-12-16 Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia Hospenthal, Duane R Waters, C Dustin Beekmann, Susan E Polgreen, Philip M Open Forum Infect Dis Major Articles BACKGROUND: Bacteremia in adult patients has traditionally been treated with extended courses of intravenous antibiotics. Data on the use of (or rapid transition to) oral therapy are limited. METHODS: Adult infectious disease physicians participating in the Infectious Diseases Society of America Emerging Infections Network (EIN) were surveyed regarding their use of oral antibiotics in patients with bacteremia. Respondents were asked to assume that patients were hemodynamically stable, recovered bacteria were susceptible to potential antibiotics, adequate source control had been achieved, and patients had adequate gastrointestinal absorption. Variables of specific bacteria, oral agent, and associated infection were included. RESULTS: A total of 655 (50%) of 1321 EIN participants responded. Under certain conditions, 88% would transition patients with Gram-negative bacteremia to complete a course of therapy with oral antibiotics; 71% would transition patients with Gram-positive bacteremia to oral agents. Only 78 (12%) respondents would not treat any bacteremic patient with oral agents. Most respondents (≥75%) were comfortable treating infections secondary to Enterobacteriaceae, Salmonella, Pseudomonas, Stenotrophomonas, Streptococcus pneumoniae, and β-hemolytic streptococci with oral agents. Fewer than 20% endorsed use of oral antibiotics for Staphylococcus aureus or in cases of endocarditis. Fluoroquinolones and trimethoprim-sulfamethoxazole were the preferred agents in Gram-negative bacteremia; linezolid and β-lactams were the preferred agents in Gram-positive bacteremia. CONCLUSIONS: In select circumstances, the majority of respondents would transition patients to oral antibiotics, in both Gram-negative and Gram-positive bacteremia. Most agreed with the use of oral agents in Gram-negative bacteremia caused by Enterobacteriaceae, but they would not use oral agents for Gram-positive bacteremia caused by S aureus or in endocarditis. Oxford University Press 2019-08-30 /pmc/articles/PMC7731529/ /pubmed/33335941 http://dx.doi.org/10.1093/ofid/ofz386 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Hospenthal, Duane R
Waters, C Dustin
Beekmann, Susan E
Polgreen, Philip M
Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia
title Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia
title_full Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia
title_fullStr Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia
title_full_unstemmed Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia
title_short Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia
title_sort practice patterns of infectious diseases physicians in transitioning from intravenous to oral therapy in patients with bacteremia
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731529/
https://www.ncbi.nlm.nih.gov/pubmed/33335941
http://dx.doi.org/10.1093/ofid/ofz386
work_keys_str_mv AT hospenthalduaner practicepatternsofinfectiousdiseasesphysiciansintransitioningfromintravenoustooraltherapyinpatientswithbacteremia
AT waterscdustin practicepatternsofinfectiousdiseasesphysiciansintransitioningfromintravenoustooraltherapyinpatientswithbacteremia
AT beekmannsusane practicepatternsofinfectiousdiseasesphysiciansintransitioningfromintravenoustooraltherapyinpatientswithbacteremia
AT polgreenphilipm practicepatternsofinfectiousdiseasesphysiciansintransitioningfromintravenoustooraltherapyinpatientswithbacteremia